Esclerodermia en el Caribe: características en una serie de casos dominicana

Balbir-Gurman, 2012, Scleroderma: New aspects in pathogenesis and treatment, Best Pract Res Clin Rheumatol, 26, 13, 10.1016/j.berh.2012.01.011 Garza-Rodríguez, 2013, [Scleroderma: An update on the pathogenesis and treatment], Rev Med Inst Mex Seguro Soc, 51, 50 Greenblatt, 2012, The immune pathogenesis of scleroderma: Context is everything, Curr Rheumatol Rep, 15, 297, 10.1007/s11926-012-0297-8 Bernatsky, 2009, Scleroderma prevalence: Demographic variations in a population-based sample, Arthritis Rheum, 61, 400, 10.1002/art.24339 Steen, 2012, A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis, Arthritis Rheum, 64, 2986, 10.1002/art.34482 Torroni, 2001, Do the four clades of the mtDNA haplogroup L2 evolve at different rates?, Am J Hum Genet, 69, 1348, 10.1086/324511 Valdivia J. Estudio determina que hay genes taínos en 15% de los dominicanos. Listín Diario [Internet]. 2010 Jun 17: La República. Párrafo 1 [citado 20 Oct 2013]. Disponible en: http://www.listindiario.com/la-republica/2010/6/17/146622/Estudio-determina-que-hay-genes-tainos-en-15-de-los-dominicanos Van den Hoogen, 2013, 2013 classification criteria for systemic sclerosis: An American College of Rheumatology/European League Against Rheumatism collaborative initiative, Arthritis Rheum, 65, 2737, 10.1002/art.38098 1980, Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, Arthritis Rheum, 23, 581, 10.1002/art.1780230510 Kreuter, 2009, AWMF Guideline no. 013/066. Diagnosis and therapy of circumscribed scleroderma, J Dtsch Dermatol Ges, 7 Suppl 6, S1 Seibold JR. Is the modified Rodnan skin score an outcome or a surrogate in trials of therapies for systemic sclerosis? En: Collection of presentations at the 3rd EULAR/EUSTAR Educational Course in Paris, France (22nd-25th of January 2009) [Internet]. 3rd EULAR/EUSTAR Educational Course; 2009 Jan 22-25; Paris, France [citado 20 Oct 2013]. [443 KB]. Disponible en: http://www.eustar.org/download/SSc_2009/Paris-2009_17_Skin_Score_JSeibold.pdf Chifflot, 2008, Incidence and prevalence of systemic sclerosis: A systematic literature review, Semin Arthritis Rheum, 37, 223, 10.1016/j.semarthrit.2007.05.003 Mayes, 2003, Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population, Arthritis Rheum, 48, 2246, 10.1002/art.11073 Rosa, 2011, Incidence and prevalence of systemic sclerosis in a healthcare plan in Buenos Aires, J Clin Rheumatol, 17, 59, 10.1097/RHU.0b013e31820e7e8d Kuo, 2011, Epidemiology and mortality of systemic sclerosis: A nationwide population study in Taiwan, Scand J Rheumatol, 40, 373, 10.3109/03009742.2011.553736 Simeon, 2003, Mortality and prognostic factors in Spanish patients with systemic sclerosis, Rheumatology (Oxford), 42, 71, 10.1093/rheumatology/keg033 Sangha, 2000, Epidemiology of rheumatic diseases, Rheumatology (Oxford), 39 Suppl 2, 3, 10.1093/rheumatology/39.suppl_2.3 Sánchez-Alonso, 2007, The other Europeans: Immigration into Latin America and the international labour market (1870-1930), Revista de Historia Económica /Journal of Iberian and Latin American Economic History (Second Series), 25, 395, 10.1017/S0212610900000185 Simeón Aznar, 2012, Registry of the Spanish network for systemic sclerosis: Clinical pattern according to cutaneous subsets and immunological status, Semin Arthritis Rheum, 41, 789, 10.1016/j.semarthrit.2011.10.004 Wang, 2013, Clinical and serological features of systemic sclerosis in a Chinese cohort, Clin Rheumatol, 32, 617, 10.1007/s10067-012-2145-7 Krzyszczak, 2011, Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies, Clin Rheumatol, 30, 1333, 10.1007/s10067-011-1751-0 Ho, 2003, The clinical relevance of autoantibodies in scleroderma, Arthritis Res Ther, 5, 80